Skip to content

The treatment and outcome of acute basilar artery occlusion: A prospective registry study in China

The treatment and outcome of acute basilar artery occlusion: A prospective registry study in China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015230
Enrollment
Unknown
Registered
2018-03-16
Start date
2018-03-31
Completion date
Unknown
Last updated
2018-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Multiple cohorts:antithrombus treatment versus intravenous thrombolysis and intravascular interventional treatment

Sponsors

Shanghai Ninth Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged = 18 years old; 2. Acute basilar artery occlusion evidenced by computed tomographic angi-ography (CTA), magnetic resonance angiography (MRA) or digital subtraction angiography (DSA); 3. Within 24 hours after the onset of stroke (Onset time is defined as patients with the symptoms of acute basilar artery occlusion, if the onset time is not clear, it would be estimated as the last time patient was seen normal), according to the guideline and latest study, the time frame for intravenous thrombolysis is 4.5h, the time frame for endovascular treatment is 24 hours; 4. Patients received one or more treatments of drug antithrombotic, intravenous thrombolysis and endovascular therapy (primarily with new stent retriever or aspiration devices, if necessary combined with angioplasty and/or stenting).

Exclusion criteria

Exclusion criteria: 1. Patients could be impossible to be followed up; 2. Cerebral hemorrhage.

Design outcomes

Primary

MeasureTime frame
Favorable outcome;

Secondary

MeasureTime frame
Modified Rankin Score (mRS);National Institutes of Health Stroke Scale score (NIHSS);The quality-of-life EuroQol-5 Dimensions (EQ-5D) score;

Countries

China

Contacts

Public ContactJian-Ren Liu, Jieqing Wan

Shanghai Ninth Hospital, Shanghai Jiao Tong University School of Medicine (JIAN-REN LIU); Renji Hospital, Shanghai Jiao Tong University School of Medicine(JIEQING WAN)

liujr021@sjtu.edu.cn+86 21 23271699-5597

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026